The role of lenalidomide in the management of myelodysplasia with del 5q.
about
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 cases.A critical review of the molecular pathophysiology of lenalidomide sensitivity in 5q - myelodysplastic syndromes.Changing the treatment paradigm in myelodysplastic syndromes.Anemia and transfusions in geriatric patients: a time for evaluation.Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
P2860
The role of lenalidomide in the management of myelodysplasia with del 5q.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The role of lenalidomide in the management of myelodysplasia with del 5q.
@ast
The role of lenalidomide in the management of myelodysplasia with del 5q.
@en
type
label
The role of lenalidomide in the management of myelodysplasia with del 5q.
@ast
The role of lenalidomide in the management of myelodysplasia with del 5q.
@en
prefLabel
The role of lenalidomide in the management of myelodysplasia with del 5q.
@ast
The role of lenalidomide in the management of myelodysplasia with del 5q.
@en
P2860
P1476
The role of lenalidomide in the management of myelodysplasia with del 5q.
@en
P2093
Charikleia Kelaidi
Virginie Eclache
P2860
P304
P356
10.1111/J.1365-2141.2007.06910.X
P407
P577
2008-02-01T00:00:00Z